We have a strong base of scientific evidence behind our experimental research project (ERP). Our pre-clinical evidence outlined on this site is compelling. But is it legal? Is it moral? Is it right for a physician to get paid to refer a patient into our ERP? To answer these questions, we reviewed the following policies, laws, regulations and guidelines:
- Right to Try
- Access to Investigational New Drugs
- AMA Ethical Guidelines
- FDA Pay to Play Ruling
- Compassionate Use Regulations
- Regulatory/Federal Regulations regarding private payment.
- Anti-kickback Regulations
Having considered this list, we concluded that there is no regulation or ethical position that precludes LGT from paying physicians to refer a willing and informed patient to our ERP.
Is it more ethical to offer a potential treatment to a patient that has no other options, or to deny it? We believe informed choice is a right. Nobody is in a better position to know the options available than the physicians.
If you would like to participate, respond to email@example.com. The process is quick, easy, and meaningful.